Medication Regimen Complexity and Unplanned Hospital Readmissions in Older People
Overview
Authors
Affiliations
Background: Medication-related problems and adverse drug events are leading causes of preventable hospitalizations. Few previous studies have investigated the possible association between medication regimen complexity and unplanned rehospitalization.
Objective: To investigate the association between discharge medication regimen complexity and unplanned rehospitalization over a 12-month period.
Method: The prospective study comprised patients aged ≥70 years old consecutively admitted to a Geriatrics Evaluation and Management (GEM) unit between October 2010 and December 2011. Medication regimen complexity at discharge was calculated using the 65-item validated Medication Regimen Complexity Index (MRCI). Cox proportional-hazards regression was used to compute unadjusted and adjusted hazard ratios (HRs) with 95% CIs for factors associated with rehospitalization over a 12-month follow-up period.
Result: Of 163 eligible patients, 99 patients had one or more unplanned hospital readmissions. When adjusting for age, sex, activities of daily living, depression, comorbidity, cognitive status, and discharge destination, MRCI (HR = 1.01; 95% CI = 0.81-1.26), number of discharge medications (HR = 1.01; 95% CI = 0.94-1.08), and polypharmacy (≥9 medications; HR = 1.12; 95% CI = 0.69-1.80) were not associated with rehospitalization. In patients discharged to nonhome settings, there was an association between rehospitalization and the number of discharge medications (HR = 1.12; 95% CI = 1.01-1.25) and polypharmacy (HR = 2.24; 95% CI = 1.02-4.94) but not between rehospitalization and MRCI (HR = 1.32; 95% CI = 0.98-1.78).
Conclusion: Medication regimen complexity was not associated with unplanned hospital readmission in older people. However, in patients discharged to nonhome settings, the number of discharge medications and polypharmacy predicted rehospitalization. A patient's discharge destination is an important factor in unplanned medication-related readmissions.
Ramos J, Alquezar-Arbe A, Juanes Borrego A, Burillo Putze G, Aguilo S, Jacob J Ther Adv Drug Saf. 2024; 15:20420986241228129.
PMID: 38323189 PMC: 10846059. DOI: 10.1177/20420986241228129.
Mendorf S, Teschner U, Lehmann T, Prell T, Muhlhammer H Trials. 2023; 24(1):668.
PMID: 37828583 PMC: 10571350. DOI: 10.1186/s13063-023-07663-9.
Jacobs D, Slazak E, Daly C, Clark C, Will S, Meaney D J Am Pharm Assoc (2003). 2023; 63(6):1722-1730.e3.
PMID: 37611896 PMC: 10900124. DOI: 10.1016/j.japh.2023.08.014.
Abdelbary A, Kaddoura R, Al Balushi S, Ahmed S, Galvez R, Ahmed A BMC Geriatr. 2023; 23(1):377.
PMID: 37337138 PMC: 10278269. DOI: 10.1186/s12877-023-04062-2.
Mills P, MacLure K Explor Res Clin Soc Pharm. 2022; 3:100065.
PMID: 35480613 PMC: 9031366. DOI: 10.1016/j.rcsop.2021.100065.